ADD-ASPIRIN trial: Principal Investigator for Oesophagi-Gastric cohort

Richard Turkington (Recipient)

Activity: Other activity typesOther

Description

A phase III, double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Period25 Oct 2017 → …
Degree of RecognitionInternational